back
Eurocare 3 Survival Analysis 1990-1994
Cancer Site Population Age Class
Acute lymphatic leukaemiaMelanoma of skin
Acute myeloid leukaemiaMultiple myeloma
ALL CANCERSNasal cavities
BladderNasopharynx
BoneNon-Hodgkin's lymphomas
BrainOesophagus
BreastOral cavity
Cervix uteriOropharynx
Choroid (melanoma)Ovary
Chronic lymphatic leukaemiaPancreas
Chronic myeloid leukaemiaPenis
ColonPleura
Corpus uteriProstate
Biliary tractRectum
Head & NeckSalivary glands
Hodgkin's diseaseSmall intestine
HypopharynxSoft tissues
KidneyStomach
LarynxTestis
LeukaemiaThyroid gland
LipTongue
Liver, PrimaryVagina and vulva
LungColon & Rectum
TyrolLatinaSweden
DenmarkModenaBasel
EindhovenParmaGeneva
Dutch RegistriesRagusaSwiss Registries
East AngliaRomagnaAmsterdam
MerseyTurinSouthWest
OxfordVareseThames
West MidlandsItalian RegistriesTrent
YorkshireCracowMalta
English RegistriesWarsawPortugal
EstoniaPolish RegistriesWales
FinlandScotlandBas Rhin
CalvadosSlovakiaMurcia
Côte d'OrSloveniaWest Bohemia
IsèreBasque CountrySassari
French RegistriesGranadaNorway
SaarlandMallorcaFerrara
IcelandNavarraMacerata
TuscanyTarragonaMunich
GenoaSpanish RegistriesVeneto
Europe
Sex
Male Female Male and Female
15-44
45-54
55-64
65-74
75-99
All ages 15-99
Eurocare-3 standard
ICSS standard
20-44
20-99
15-54
75-84
85-99
Time from diagnosis
1year
2years
3years
4years
5years
Period of Diagnosis
Output Indicators
Number of cases Observed Survival, Interval (OSI) Relative Survival, Interval (RSI) Relative SE's, Interval (RSEI)
Alive at Start Observed Survival, Cum (OSC) Relative Survival, Cum (RSC) Relative SE's, Cum (RSEC)
Dead Expected Survival, Interval (ESI) Observed SE's, Interval (OSEI) RSC: Lower bound
Lost to Follow Up Expected Survival, Cum (ESC) Observed SE's, Cum (OSEC) RSC: Upper bound

Valid XHTML 1.0 Strict